Related Experiment Video
Updated: Oct 17, 2025

05:03
A Fluorescent Intravital Imaging Approach to Study Load-Induced Calcium Signaling Dynamics in Mouse Osteocytes
Published on: February 24, 2023
811
Identifying mineral decrement with bone injury by quantifying osteocalcin on current-volt sensor
Huanjie Bi1, Peimin Bian2, Subash C B Gopinath3,4
1The Second Department of Orthopedics, Tangshan Gongren Hospital, Tangshan, Hebei, China.
Biotechnology and Applied Biochemistry
|October 8, 2021
Summary
This study developed a novel point-of-care sensor to detect osteocalcin, a key biomarker for osteoporosis. This innovation offers a cost-effective and accessible method for diagnosing bone metabolism and prognosis.
Area of Science:
- Biomedical Engineering
- Biochemistry
- Materials Science
Background:
- Osteoporosis is a debilitating bone disease characterized by decreased bone mineral density and increased fracture risk.
- Current diagnostic methods like radiological techniques are costly, involve radiation exposure, and require specialized personnel.
- There is a need for accessible, cost-effective, and non-invasive diagnostic tools for osteoporosis.
Purpose of the Study:
- To develop a point-of-care system for detecting osteocalcin, a biomarker for bone metabolism.
- To create an electrochemical sensor for rapid and accurate osteoporosis diagnosis.
- To establish a cost-effective alternative to existing radiological diagnostic methods.
Main Methods:
- An electrochemical sensor was fabricated by immobilizing anti-osteocalcin antibodies onto a silane-modified iron electrode.
- The sensor's performance was evaluated by measuring osteocalcin levels using a current-volt sensing approach.
- Specificity was confirmed by demonstrating the absence of binding with control proteins.
Main Results:
- The developed sensor achieved a detection limit of 100 pg/ml for osteocalcin.
- A linear detection range was established from 0.01-3000 ng/ml with a high determination coefficient (R² = 0.9319).
- The sensor demonstrated specific detection of osteocalcin, with no significant binding to control proteins.
Conclusions:
- The developed point-of-care system effectively detects osteocalcin, indicating its potential for osteoporosis diagnosis.
- This sensor offers a promising, accessible, and cost-effective tool for assessing bone metabolism and prognosis.
- Further development could lead to widespread clinical application for early osteoporosis detection and management.

